Roche extends $4.3 billion takeover offer for Spark Therapeutics to September 3

The decision comes in the wake of continuing regulatory scrutiny by antitrust regulators in the UK and U.S. over its takeover offer.

Following a continuation of regulatory reviews in the United States and Britain, Roche and Spark Therapeutics announced another extension of their $4.3 billion merger.

Roche’s offer for Spark is now valid upto September 3, said while adding that the terms and conditions of its offer remain unchanged.

“The parties remain committed to the transaction and are working cooperatively and expeditiously with the Federal Trade Commission and UK Competition and Markets Authority,” said Roche.

Categories: Creativity, Entrepreneurship, HR & Organization, Regulations & Legal, Strategy

Tags: , , , , , , , , , , , , , , ,

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: